Ryan Specialty Holdings, Inc. (NYSE:RYAN) Given Consensus Rating of “Hold” by Analysts

Shares of Ryan Specialty Holdings, Inc. (NYSE:RYANGet Free Report) have earned a consensus rating of “Hold” from the twelve brokerages that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $74.40.

RYAN has been the topic of a number of research reports. Morgan Stanley initiated coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price on the stock. Wells Fargo & Company dropped their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 14th. Barclays increased their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. Finally, Keefe, Bruyette & Woods dropped their target price on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Friday, January 10th.

Read Our Latest Analysis on RYAN

Ryan Specialty Trading Up 0.2 %

RYAN opened at $68.75 on Wednesday. The stock has a market capitalization of $18.00 billion, a PE ratio of 89.29, a P/E/G ratio of 1.19 and a beta of 0.72. The firm’s fifty day moving average price is $65.53 and its 200 day moving average price is $67.18. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty has a 12-month low of $44.84 and a 12-month high of $75.97.

Insider Activity at Ryan Specialty

In other news, Director David P. Bolger sold 7,055 shares of the firm’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $70.88, for a total transaction of $500,058.40. Following the completion of the transaction, the director now owns 78,149 shares in the company, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of the firm’s stock in a transaction dated Monday, January 13th. The shares were sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the transaction, the director now owns 45,409 shares of the company’s stock, valued at approximately $2,954,309.54. This trade represents a 39.35 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 323,506 shares of company stock worth $21,407,851 in the last 90 days. Corporate insiders own 11.10% of the company’s stock.

Institutional Trading of Ryan Specialty

A number of hedge funds have recently bought and sold shares of RYAN. Freestone Grove Partners LP purchased a new stake in shares of Ryan Specialty in the fourth quarter worth approximately $13,842,000. Comerica Bank raised its position in Ryan Specialty by 562.4% during the fourth quarter. Comerica Bank now owns 209,079 shares of the company’s stock valued at $13,415,000 after acquiring an additional 177,517 shares in the last quarter. Kapitalo Investimentos Ltda bought a new position in Ryan Specialty during the fourth quarter valued at approximately $36,000. Schonfeld Strategic Advisors LLC raised its position in Ryan Specialty by 468.3% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 122,767 shares of the company’s stock valued at $7,877,000 after acquiring an additional 101,164 shares in the last quarter. Finally, Northern Trust Corp raised its position in Ryan Specialty by 20.5% during the fourth quarter. Northern Trust Corp now owns 891,112 shares of the company’s stock valued at $57,174,000 after acquiring an additional 151,391 shares in the last quarter. 84.82% of the stock is owned by hedge funds and other institutional investors.

About Ryan Specialty

(Get Free Report

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Read More

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.